We have previously shown that MBP-1 acts as a general transcriptional repressor and forced expression of MBP-1 exerts an antiproliferative effect on a number of human cancer cells. In this report, we have investigated the role of endogenous MBP-1 in cell growth regulation. For this, we generated human prostate cancer (PC3) cells stably transfected with short hairpin RNA (shRNA) targeting MBP-1. We have observed retarded growth and longer doubling time of MBP-1 knockdown PC3 cells as compared to control mock transfected PC3 cells. FACS analysis suggested that PC3 cells expressing MBP-1 specific siRNA accumulate during G2/M phase of the cell cycle. Further analysis suggested that depletion of MBP-1 is associated with reduction of cyclins A and B1 expression when compared with that of control cells. A delayed induction of cyclins A and B1 expression was observed in MBP-1 depleted PC3 cells (PC3-4.2) upon serum stimulation, although the level of expression was much lower than that of control PC3 cells. Supplementation of MBP-1 in PC3-4.2 cells restores cyclins A and B1 expression. Together, these results suggest that knockdown of MBP-1 in prostate cancer cells perturbs cell proliferation by inhibiting cyclins A and B1 expression.
induces cell death in a number of cancer cells (5, 6) and regresses human breast and prostate tumor growth in nude mice (7, 8) . bp and can silence endogenous genes in a sequence-specific manner and reduce the production of specific proteins (10, 11) . In this study, we have used MBP-1 targeted siRNA to inhibit the expression of endogenous MBP-1 in human androgen-independent prostate cancer cells and determined its effect on prostate cancer cell growth. We have observed that depletion of MBP-1 in human prostate cancer cells resulted in inhibition of cyclins A and B1 expression and delayed cell cycle progression.
EXPERIMENTAL PROCEDURES
Cell culture. Androgen-independent human prostate cancer cells (PC3) and human embryonic kidney cells (293) were procured from ATCC and maintained in DMEM with 10% fetal bovine serum (Invitrogen). 
Construction of MBP

RESULTS
Inhibition of MBP-1 by RNA interference.
We have identified two potent siRNAs to transiently knockdown endogenous MBP-1 in prostate cancer cells (6) , and cloned these shRNAs Cell lysates from these clones were analyzed for the detection of endogenous MBP-1 by Western blot using a specific monoclonal antibody.
Similar results were observed at the protein level 
